Hsairi M
Dridi Y
Ben Abdallah M
Boussen H
Ben Hamida A


Breast cancer is the principle cancer among female cancer in Tunisia. It represents 30% of the woman's cancers with about 1000 new cases per year. The main intervention control is mass screening using mammography in to reduce breast cancer mortality. Breast cancer screening efficacy in term of breast cancer mortality reduction is closely related to incidence and survival of this cancer. National Office of Family and Population (ONFP) conducted a pilot experience of breast cancer mass screening using the mammography in place. The main objective of this study is to calculate the potential number of life years saved through this pilot experience of the ONFP. For the methodology, we used the software Dismod (Disease Model) for the evaluation of the prevalence and the duration of the cancer of the breast in the governorate, as well as to estimate the number of life years saved. The potential breast cancer mortality reduction is 30% for women aged of 50 at 69 years, and 10% for those aged of 40 at 49 years. Breast cancer incidence in Ariana according to age for the period 1995-1998, has been calculated from the data base of cancer registry of the North of Tunisia. According to Dismod, mean duration in the absence of screening, is 11.12 years for the age group 40 to 49 years and 9.57 for the age group 50 at 69 years. Screening would increase these duration means of 2.22 years and 1.71 years, respectively for age groups 40 to 49 years and 50 at 69 years. The number of life years saved for 1000 women is of 2.97 years. In conclusion breast cancer screening using mammography would be actually little benefit in Tunisia. Mammography should be reserved for the diagnosis of the suspected cases and screening for high risk women.


Breast cancer, screening, mammography, efficacy



  1. Ben Abdallah M, Zheni S. Registre des cancers Nord Tunisie - 1995-1998. Tunis, Institut Salah Azaiez, 2004 :147p.
  2. Sellami A, Jlidi R, Hsairi M, Achour N. Registre du cancer du Sud Tunisien, 1997-1999. Sfax, Hôpital Habib Bourguiba 2002, 67p.
  3. Maalej M, Hentati D, Messai T, Kochbati L, El May A, Mrad K, Romdhane KB, Ben Abdallah M, Zouari B. Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study. Bull Cancer. 2008;95(2):E5-9.
  4. Maalej M, Frikha H ,Ben Salem S, Daoud J et al . Le cancer du sein en Tunisie: étude clinique et épidémiologique. Bull cancer 1999;86(3): 302-306
  5. WHO. DisMod II
  6. Demissie K, Mills OF, Rhoads GG. Empirical comparison of the results of randomized controlled trials and case control studies in evaluating the effectiveness of screening mammography. J Clin Epidemiol 1998;51:81-91
  7. Institut National de la Statistique Annuaire statistique 2003. Tunis, INS, 2004.
  8. Ben Gobrane H, Radhouane F , Rahal K, Ben Ayed F, Ben Abdallah M, Achour N, Hsairi M. Pronostic du cancer du sein en Tunisie . Eastern Mediterranean Health Journal 2007 Mar- Apr;13(2):309-18. French.
  9. Van Ineveld BM, van Oortmarssen GJ, de Koning HJ, Boer R, van der Maas PJ How cost-effective is breast cancer screening in different EC countries? source : Eur J Cancer. 1993 ; 29A (12) : 1663-8.
  10. Leivo T, Sintonen H, Tuominen R, Hakama M, Pukkala E, Heinonen OP The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992 Cancer. 1999 Aug 15;86(4):638-46.
  11. Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 1971;215:1777-85.
  12. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977;39 (Suppl 6):2772-82.
  13. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten-to fourteenyear effect of screening on breast cancer mortality. J Nat Cancer Inst 1982;69:349-55.
  14. Tabar L, Fagerberg CJG, Gad A, Baldetorp L, Holmberg LH, Grontoft O et al. Reduction in mortality from breast cancer after mass screening with mammogrphy. Randomized trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 8433:929-32.
  15. Tabar L, Fagerberg F, Duffy SW, Day NE. The swedish two county trial of mammography screening for breast cancer. Recent results and calculation of benefit. J Epidemiol Comm Health 1989;43:107-14.
  16. Miller AB, Howe GR, Wall C. The national study of breast cancer screening. Protocol for a canadian randomized controlled trial of screening for breast cancer in women. Clin Invest Med 1981;4:227-58.
  17. Miller AB, Bulbrook RD. UICC multidisciplinary project on breast cancer. The epidemiology, aetiology and prevention of breast cancer. Int J Cancer 1986;37:173-7.
  18. Roberts MM, Alexander FE, Anderson TJ, Chetty U, Donnan PT, Forest P et al. Edinburg trial of screening for breast cancer : mortality at seven years. Lancet 1990;335:241-6.
  19. Wolfe JN. Breast cancer screening. A brief historical review. Breast Cancer Res Treat 1991;18(Suppl):80-92.
  20. Organisation Mondiale de la Santé Programmes Nationaux de Lutte contre le Cancer. Politiques et Principales Gestionnaires. Genève : OMS 1996:139P.
  21. Comité National de Pilotage du programme de dépistage systématique du cancer du sein 29 et 30 Janvier 1996,Marseille. Compte rendu. Paris : CNPPDSCS,Ministère du Travail et des Affaires Sociales , Direction Générale de la Santé 1996 :87P. 32- Wright CJ, Mueller CB. Screening mammography and public health policy : the need for perspective. Lancet 1995;346:29-32.
  22. Parlement Européen Programmes de dépistage du cancer du sein dans l'Union Européenne. Document de travail. Strasbourg : Parlement Européen, Direction Générale des Études 1995:110P
  23. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.
  24. Ferrini R, Mannino E, Ramsdell E, Hill L. Breast cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare. Int J Cancer 1996;68:693-9.
  25. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacity of breast cancer screening by age. New results from the Swedish two-county trial. Cancer 1995;75:2507-17.